Ribonucleotide reductase (RNR) is an essential enzyme in all organisms.
INTRODUCTION
4 nucleotide binding component of class Ia RNRs is a homodimeric protein with four, pairwise identical, allosteric sites. The three-dimensional structure of E. coli class Ia RNR identifies two identical specificity sites located at the polypeptide interface, and two identical overall activity sites located at the Nterminal domain of each polypeptide (14) .
Several RNRs conform to the allosteric substrate specificity regulation of the class Ia enzymes, whereas hitherto characterized class Ib and class II RNRs lack the overall activity control. The class Ia enzymes from bacteriophage T4 and the parasite Trypanosoma brucei also lack a general negative overall activity control (15, 16) . The class III enzyme from E. coli seems most divergent, and has one allosteric site that controls reduction of pyrimidine ribonucleotides and another site that controls reduction of purine ribonucleotides (17). Recently, the allosteric regulation of the class III RNR from Lactococcus lactis was investigated and found to be similar but not identical to that of class III RNR from E. coli (18).
The three-dimensional structure of the bacteriophage T4-induced class III RNR was recently solved to high resolution (19). Interestingly, the structures of the T4 class III RNR and the class Ia RNR of the E. coli host have very similar folds and active site regions, whereas the quaternary interactions within the dimers are different (19, 20) . Since one type of allosteric sites is located at the dimer interface, and the binding of dATP to these sites is different in the two proteins (14,19), we were anxious to find out whether the apparent differences in mode of allosteric regulation between the well-characterized class Ia RNR and the class III enzymes were related to these structural differences.
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EXPERIMENTAL PROCEDURES
Materials -[ 3 H]-labeled nucleotides were from Amersham Pharmacia
Biotech or NEN™ Life Science products. They were supplied in ethanol that was removed in a speedvac and the remaining nucleotide was dissolved in 25 mM unlabeled nucleotide. All unlabeled nucleotides were from Pharmacia Biotech. The filters used for the ultrafiltration assay were Ultrafree-MC filter units with polysulfone PTTK membranes from Millipore with a molecular cutoff value of 30000.
Aerobic overexpression and purification of NrdD 1 and
NrdD(G580A):NrdG -NrdD, or the complex NrdD(G580A):NrdG lacking the site of the glycyl radical (21), were overexpressed and purified essentially as described in (22,23) with one additional purification step. The last step used an anionic exchange mono-Q column from Pharmacia Biotech, which was eluted with a NaCl gradient, and gave sufficiently pure protein for the ultrafiltration assay.
Ultrafiltration assay -The ultrafiltration method for determination of nucleotide dissociation constants has been described in (12 Table I ). The number of binding sites for dATP was higher for the complex than for the isolated NrdD, but not for dGTP or dTTP ( Table I ). The NrdG protein has a binding site for S-adenosylmethionine (24) and it is plausible that dATP may bind also to this site. The average K D values for binding of dATP, dGTP, and dTTP to the isolated NrdD are summarized in Table I . The dissociation constants were all in the µmolar range, with the lowest K D for dGTP, followed by dTTP, and dATP. The number of binding sites for these nucleotides were close to 2 sites per NrdD dimer ( Table   I ).
The dissociation constant for ATP was far beyond the detection limit of the ultrafiltration assay (ca. 0.1-0.2 mM; Slaby and Sjöberg, unpublished observations), and had to be determined indirectly (see below). Also binding of dCTP, and the substrate ribonucleotides, both in absence and presence of the putative prime positive effector, were far beyond our detection limits. (Table I) .
T4 NrdD contains only one type of allosteric nucleotide binding site -
Allosteric regulation of CTP reduction -Our standard enzymatic activity assay uses CTP as a substrate. From this assay, it was clear that both ATP and dATP are positive effectors for CTP reduction (Table II) . Also seen is that the enzyme has an intrinsic ability to reduce CTP in the absence of a positive allosteric effector. Addition of ATP increased the specific activity of CTP reduction 1.6 times and addition of dATP doubled the specific activity. Addition of dTTP or dGTP resulted in a drastic decrease of the CTP reduction to 5-10% of the basal, non-regulated CTP reduction (data not shown).
Allosteric regulation in nucleotide mixtures -To identify prime allosteric
effectors for the other substrates we used the mixed-substrate assay with equal concentrations (1.5 mM) of all nucleoside triphosphates, as described in (16) .
This assay gives a more "in vivo"-like situation in that reduction of all four substrates is monitored simultaneously. The conditions were the same as for the CTP activity assay, except that the effector concentrations were lower (0.2 mM) for technical reasons.
Initial experiments were designed to measure substrate reduction in the absence of effector nucleotides. In one set of experiments we included all four substrates; ATP may act both as substrate and as allosteric effector in this case.
In another set of experiments we excluded ATP from the substrate mix. When only CTP, GTP and UTP were included, only CTP was reduced (Table III) . This is equivalent to the non-regulated reduction of CTP observed in the CTP activity assay (Table II) . When all four substrates were included, the reduction of CTP was approximately twice as high (Table III) . A corresponding increase was seen when ATP acted as a positive effector in the CTP activity assay (Table   II) . Likewise, CTP reduction was increased twice when dATP was used as allosteric effector in the mixed-substrate assay, but no measurable reduction of ATP, GTP or UTP occurred (Table III) .
When dGTP and dTTP were added as allosteric effectors, the reduction pattern becomes quite complex. As shown in Table III , dGTP is clearly the prime effector for ATP reduction, and dTTP is the prime effector for GTP reduction. However, other substrates are reduced as well, but to a lower extent.
One interpretation of the results is that dGTP and dTTP are general positive effectors for all substrates, but as can be seen in Table III , this is not the case.
No GTP is reduced in the presence of dGTP, and very little CTP is reduced in the presence of dTTP. Instead, we favor the explanation that the "in vivo"-like conditions permit the deoxyribonucleotide products to act as positive effectors directly when they have been formed. Assays incubated for up to 20 min support this conclusion, as will be shown below. We also tested dUTP as allosteric effector although this nucleotide has never been observed to act as an allosteric effector for other RNRs. The results were very similar to those for dTTP
showing that the similarity of the two nucleotides transmits to their allosteric effects on T4 NrdD.
When dCTP was added as allosteric effector, both CTP and ATP were reduced (Table III) . The positive effect of dCTP on ATP reduction competed with ATP to act as a positive effector for CTP reduction.
Surprisingly, we did not detect any significant UTP reduction. There is a very low level of UTP reduction at longer incubation times (0.13-0.26 nmoles formed after 20 min), but not to an extent comparable to the other substrates.
UTP reduction is often coregulated with CTP reduction in other RNRs (7, 15, 17) .
We therefore omitted CTP from the substrate mixture, both with and without ATP or dATP as allosteric effector, but neither in absence of nor in presence of other effector/substrate combinations, did we detect any UTP reduction (data not shown).
Time curves mimic an in vivo situation -Further support for our
interpretations of the four-substrate assays were obtained in time curve experiments with dGTP, dTTP or dCTP as effector nucleotide. Figure 5A shows that use of dGTP as effector initially promotes ATP reduction, whereas the resulting build up of dATP later promotes CTP reduction. After 15 min of incubation CTP reduction dominates over ATP reduction (Fig. 5A) . Addition of dTTP results initially in GTP reduction (Fig. 5B ). After 5 min of incubation enough dGTP, which has the lowest K D of all allosteric effectors, has been formed to promote ATP reduction, and from 10 min onwards dATP-promoted CTP reduction dominates (Fig. 5B) . With dCTP as effector nucleotide, the reduction of CTP was rapid and efficient (Fig. 5C ). As discussed earlier, this could represent the non-regulated CTP reduction. Formation of dATP was much slower, and even lower but significant amounts of dGTP were produced. The low reduction of ATP and GTP can probably not be ascribed to dCTP as allosteric effector, since the same pattern was seen when CTP was excluded from the substrate mix (data not shown). Figure 5D shows the total amount of deoxyribonucleotides produced in each experiment. More NTPs were reduced with dCTP as effector than with dGTP or dTTP.
in general are lower during anaerobiosis than aerobiosis, in T4-infected as well as uninfected E. coli (26-28), the K D values obtained by us (Table I) is efficiently dephosphorylated by the T4-specific enzyme dCTPase/dUTPase to dCMP, which in turn is the substrate for the T4-specific dCMP hydroxymethylase (30). In the four-substrate assay we also observed that dUTP had the same allosteric effects as dTTP (Table III) . Again, this is plausibly not physiologically significant since both the host cell encoded enzyme dUTPase and the T4 encoded dCTPase/dUTPase will convert any dUTP to dUMP, to enable subsequent dTTP formation via the thymidylate synthase/kinase pathway (29,30).
Most unexpectedly, we were unable to detect any significant UTP reduction in the four-substrate assays, even when the related substrate CTP was omitted from the mixtures. In the aerobic T4 class Ia ribonucleoside diphosphate reductase, the corresponding substrate UDP has a higher K M than the other NDP substrates, and more than two thirds of the dTTP pool is derived from CDP reduction via the dCMP deaminase and thymidylate synthase pathways (31,32). The enzyme dCMP deaminase is allosterically regulated, positively by dCTP and hm-dCTP, and negatively by dTTP (30,33) . Likewise, the allosterically regulated enzyme dCMP hydroxymethylase is feed-back regulated by hm-dCMP (30,33). It would thus be possible for T4 to balance the relative concentrations of dTTP and hm-dCTP via these allosterically regulated pathways, even in the absence of UTP reduction (cf. Fig. 6 ). The very efficient CTP reduction, compared to the reduction of GTP and ATP (Fig. 5B) , speaks in favor of this suggestion. At this point we can, however, not exclude that the four-substrate assay lacks a suitable positive allosteric effector for UTP reduction, as e.g. the allosteric effects of hm-dCTP has not been tested.
However, the aerobic T4 class Ia RNR, which is very similar to the T4 class III enzyme in its allosteric behavior, responds the same to hm-dCTP and dCTP as allosteric effectors (15, 25) .
The allosteric regulation of T4 induced class III RNR is similar to that of the class Ib RNR from Salmonella typhimurium (34) and the class II enzymes (35-38), i.e. RNRs with only one type of allosteric site (Table IV) . This regulation is also seen for the class Ia RNR from phage T4 (15) . E. coli NrdD (class III), on the other hand, contains two types of allosteric sites; one site regulates reduction of the pyrimidine substrates (CTP and UTP) and the other reduction of the purine substrates (ATP and GTP) (17). Class Ia enzymes also have two different types of allosteric sites; here one site regulates substrate specificity and another N-terminally located site regulates the overall activity of the enzyme, by forming an active enzyme when ATP binds and an inactive enzyme when dATP binds (Table IV) . Even though the allosteric regulation appears different for class Ia RNRs and E. coli class III RNR, a combination of sequence comparisons and structural considerations (14, 19) suggests that the overall location of the allosteric sites in all three RNR classes are similar. One type of allosteric site (the overall regulatory site in class Ia and the pyrimidine regulatory site in E. coli class III) is located in the N-terminal domain, and the other site (the allosteric specificity site in class Ia and the purine regulatory site in E. coli class III) is located at the dimer interface (Table IV) The presence of only one allosteric site in T4 NrdD was expected from sequence and structure comparisons of RNRs showing that the T4 class III RNR lacks the residues corresponding to the N-terminal domain (14, 19) . Also the class Ia RNR from phage T4 lacks negative allosteric control (15), even though it comprises a N-terminal domain. It has been suggested that it is advantageous for viruses to encode RNRs that lack negative allosteric control, as this will allow a high dNTP flux to multiple replication forks and promote rapid lytic growth (39). At the extreme end are the herpes viruses, whose RNRs lack both negative and positive allosteric regulation (3, 4) . 
